0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Sheep and Goat Pox Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-15E12250
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Sheep and Goat Pox Vaccines Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Sheep and Goat Pox Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-15E12250
Report
September 2024
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sheep and Goat Pox Vaccines - Market Size

The global market for Sheep and Goat Pox Vaccines was estimated to be worth US$ 58 million in 2023 and is forecast to a readjusted size of US$ 72 million by 2030 with a CAGR of 2.8% during the forecast period 2024-2030

Sheep and Goat Pox Vaccines - Market

Sheep and Goat Pox Vaccines - Market

A single vaccine against sheep and goat pox (capripox) has been developed to protect sheep and goats throughout the capripox enzootic area.
The increasing incidence of Sheep and Goat Pox, a contagious viral disease affecting small ruminants, is driving the demand for vaccines. Factors such as the growing livestock industry, rising awareness about animal health, and government initiatives for disease control contribute to market expansion. Key players in the market are focusing on product development and strategic collaborations to gain a competitive advantage. Advancements in vaccine technology, such as the use of recombinant DNA techniques, are expected to fuel market growth. However, challenges such as regulatory hurdles and limited availability of vaccines in certain regions may impede market progress. Overall, the Sheep and Goat Pox vaccines market is projected to experience substantial growth in the coming years.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sheep and Goat Pox Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sheep and Goat Pox Vaccines by region & country, by Type, and by Application.
The Sheep and Goat Pox Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sheep and Goat Pox Vaccines.
Market Segmentation

Scope of Sheep and Goat Pox Vaccines - Market Report

Report Metric Details
Report Name Sheep and Goat Pox Vaccines - Market
Forecasted market size in 2030 US$ 72 million
CAGR 2.8%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Sheep
  • Goat
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Agrovet, Biopharma, Dollvet, FGBI - Federal Centre for Animal Health, Hester Biosciences Limited, Indian Immunologicals Limited, Institut Pasteur d'Algerie, Intervac (PVT) Ltd., JOVAC, Tiankang Biopharmacuetical, Vetal Company, Veterinary Research Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Sheep and Goat Pox Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Sheep and Goat Pox Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Sheep and Goat Pox Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Sheep and Goat Pox Vaccines - Market size in 2030?

Ans: The Sheep and Goat Pox Vaccines - Market size in 2030 will be US$ 72 million.

Who are the main players in the Sheep and Goat Pox Vaccines - Market report?

Ans: The main players in the Sheep and Goat Pox Vaccines - Market are Agrovet, Biopharma, Dollvet, FGBI - Federal Centre for Animal Health, Hester Biosciences Limited, Indian Immunologicals Limited, Institut Pasteur d'Algerie, Intervac (PVT) Ltd., JOVAC, Tiankang Biopharmacuetical, Vetal Company, Veterinary Research Institute

What are the Application segmentation covered in the Sheep and Goat Pox Vaccines - Market report?

Ans: The Applications covered in the Sheep and Goat Pox Vaccines - Market report are Sheep, Goat

What are the Type segmentation covered in the Sheep and Goat Pox Vaccines - Market report?

Ans: The Types covered in the Sheep and Goat Pox Vaccines - Market report are Attenuated Live Vaccines, Killed Vaccines

Recommended Reports

Livestock Vaccine Markets

Genetic Engineering Vaccines

Veterinary Care Industry

1 Market Overview
1.1 Sheep and Goat Pox Vaccines Product Introduction
1.2 Global Sheep and Goat Pox Vaccines Market Size Forecast
1.2.1 Global Sheep and Goat Pox Vaccines Sales Value (2019-2030)
1.2.2 Global Sheep and Goat Pox Vaccines Sales Volume (2019-2030)
1.2.3 Global Sheep and Goat Pox Vaccines Sales Price (2019-2030)
1.3 Sheep and Goat Pox Vaccines Market Trends & Drivers
1.3.1 Sheep and Goat Pox Vaccines Industry Trends
1.3.2 Sheep and Goat Pox Vaccines Market Drivers & Opportunity
1.3.3 Sheep and Goat Pox Vaccines Market Challenges
1.3.4 Sheep and Goat Pox Vaccines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sheep and Goat Pox Vaccines Players Revenue Ranking (2023)
2.2 Global Sheep and Goat Pox Vaccines Revenue by Company (2019-2024)
2.3 Global Sheep and Goat Pox Vaccines Players Sales Volume Ranking (2023)
2.4 Global Sheep and Goat Pox Vaccines Sales Volume by Company Players (2019-2024)
2.5 Global Sheep and Goat Pox Vaccines Average Price by Company (2019-2024)
2.6 Key Manufacturers Sheep and Goat Pox Vaccines Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Sheep and Goat Pox Vaccines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Sheep and Goat Pox Vaccines
2.9 Sheep and Goat Pox Vaccines Market Competitive Analysis
2.9.1 Sheep and Goat Pox Vaccines Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Sheep and Goat Pox Vaccines Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sheep and Goat Pox Vaccines as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Attenuated Live Vaccines
3.1.2 Killed Vaccines
3.2 Global Sheep and Goat Pox Vaccines Sales Value by Type
3.2.1 Global Sheep and Goat Pox Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sheep and Goat Pox Vaccines Sales Value, by Type (2019-2030)
3.2.3 Global Sheep and Goat Pox Vaccines Sales Value, by Type (%) (2019-2030)
3.3 Global Sheep and Goat Pox Vaccines Sales Volume by Type
3.3.1 Global Sheep and Goat Pox Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Sheep and Goat Pox Vaccines Sales Volume, by Type (2019-2030)
3.3.3 Global Sheep and Goat Pox Vaccines Sales Volume, by Type (%) (2019-2030)
3.4 Global Sheep and Goat Pox Vaccines Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Sheep
4.1.2 Goat
4.2 Global Sheep and Goat Pox Vaccines Sales Value by Application
4.2.1 Global Sheep and Goat Pox Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sheep and Goat Pox Vaccines Sales Value, by Application (2019-2030)
4.2.3 Global Sheep and Goat Pox Vaccines Sales Value, by Application (%) (2019-2030)
4.3 Global Sheep and Goat Pox Vaccines Sales Volume by Application
4.3.1 Global Sheep and Goat Pox Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Sheep and Goat Pox Vaccines Sales Volume, by Application (2019-2030)
4.3.3 Global Sheep and Goat Pox Vaccines Sales Volume, by Application (%) (2019-2030)
4.4 Global Sheep and Goat Pox Vaccines Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Sheep and Goat Pox Vaccines Sales Value by Region
5.1.1 Global Sheep and Goat Pox Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sheep and Goat Pox Vaccines Sales Value by Region (2019-2024)
5.1.3 Global Sheep and Goat Pox Vaccines Sales Value by Region (2025-2030)
5.1.4 Global Sheep and Goat Pox Vaccines Sales Value by Region (%), (2019-2030)
5.2 Global Sheep and Goat Pox Vaccines Sales Volume by Region
5.2.1 Global Sheep and Goat Pox Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Sheep and Goat Pox Vaccines Sales Volume by Region (2019-2024)
5.2.3 Global Sheep and Goat Pox Vaccines Sales Volume by Region (2025-2030)
5.2.4 Global Sheep and Goat Pox Vaccines Sales Volume by Region (%), (2019-2030)
5.3 Global Sheep and Goat Pox Vaccines Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Sheep and Goat Pox Vaccines Sales Value, 2019-2030
5.4.2 North America Sheep and Goat Pox Vaccines Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Sheep and Goat Pox Vaccines Sales Value, 2019-2030
5.5.2 Europe Sheep and Goat Pox Vaccines Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Sheep and Goat Pox Vaccines Sales Value, 2019-2030
5.6.2 Asia Pacific Sheep and Goat Pox Vaccines Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Sheep and Goat Pox Vaccines Sales Value, 2019-2030
5.7.2 South America Sheep and Goat Pox Vaccines Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sheep and Goat Pox Vaccines Sales Value, 2019-2030
5.8.2 Middle East & Africa Sheep and Goat Pox Vaccines Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sheep and Goat Pox Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sheep and Goat Pox Vaccines Sales Value
6.2.1 Key Countries/Regions Sheep and Goat Pox Vaccines Sales Value, 2019-2030
6.2.2 Key Countries/Regions Sheep and Goat Pox Vaccines Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Sheep and Goat Pox Vaccines Sales Value, 2019-2030
6.3.2 United States Sheep and Goat Pox Vaccines Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sheep and Goat Pox Vaccines Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sheep and Goat Pox Vaccines Sales Value, 2019-2030
6.4.2 Europe Sheep and Goat Pox Vaccines Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sheep and Goat Pox Vaccines Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sheep and Goat Pox Vaccines Sales Value, 2019-2030
6.5.2 China Sheep and Goat Pox Vaccines Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sheep and Goat Pox Vaccines Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sheep and Goat Pox Vaccines Sales Value, 2019-2030
6.6.2 Japan Sheep and Goat Pox Vaccines Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sheep and Goat Pox Vaccines Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sheep and Goat Pox Vaccines Sales Value, 2019-2030
6.7.2 South Korea Sheep and Goat Pox Vaccines Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sheep and Goat Pox Vaccines Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sheep and Goat Pox Vaccines Sales Value, 2019-2030
6.8.2 Southeast Asia Sheep and Goat Pox Vaccines Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sheep and Goat Pox Vaccines Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sheep and Goat Pox Vaccines Sales Value, 2019-2030
6.9.2 India Sheep and Goat Pox Vaccines Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sheep and Goat Pox Vaccines Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Agrovet
7.1.1 Agrovet Company Information
7.1.2 Agrovet Introduction and Business Overview
7.1.3 Agrovet Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Agrovet Sheep and Goat Pox Vaccines Product Offerings
7.1.5 Agrovet Recent Development
7.2 Biopharma
7.2.1 Biopharma Company Information
7.2.2 Biopharma Introduction and Business Overview
7.2.3 Biopharma Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Biopharma Sheep and Goat Pox Vaccines Product Offerings
7.2.5 Biopharma Recent Development
7.3 Dollvet
7.3.1 Dollvet Company Information
7.3.2 Dollvet Introduction and Business Overview
7.3.3 Dollvet Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Dollvet Sheep and Goat Pox Vaccines Product Offerings
7.3.5 Dollvet Recent Development
7.4 FGBI - Federal Centre for Animal Health
7.4.1 FGBI - Federal Centre for Animal Health Company Information
7.4.2 FGBI - Federal Centre for Animal Health Introduction and Business Overview
7.4.3 FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.4.4 FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Product Offerings
7.4.5 FGBI - Federal Centre for Animal Health Recent Development
7.5 Hester Biosciences Limited
7.5.1 Hester Biosciences Limited Company Information
7.5.2 Hester Biosciences Limited Introduction and Business Overview
7.5.3 Hester Biosciences Limited Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Hester Biosciences Limited Sheep and Goat Pox Vaccines Product Offerings
7.5.5 Hester Biosciences Limited Recent Development
7.6 Indian Immunologicals Limited
7.6.1 Indian Immunologicals Limited Company Information
7.6.2 Indian Immunologicals Limited Introduction and Business Overview
7.6.3 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Product Offerings
7.6.5 Indian Immunologicals Limited Recent Development
7.7 Institut Pasteur d'Algerie
7.7.1 Institut Pasteur d'Algerie Company Information
7.7.2 Institut Pasteur d'Algerie Introduction and Business Overview
7.7.3 Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Product Offerings
7.7.5 Institut Pasteur d'Algerie Recent Development
7.8 Intervac (PVT) Ltd.
7.8.1 Intervac (PVT) Ltd. Company Information
7.8.2 Intervac (PVT) Ltd. Introduction and Business Overview
7.8.3 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Product Offerings
7.8.5 Intervac (PVT) Ltd. Recent Development
7.9 JOVAC
7.9.1 JOVAC Company Information
7.9.2 JOVAC Introduction and Business Overview
7.9.3 JOVAC Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.9.4 JOVAC Sheep and Goat Pox Vaccines Product Offerings
7.9.5 JOVAC Recent Development
7.10 Tiankang Biopharmacuetical
7.10.1 Tiankang Biopharmacuetical Company Information
7.10.2 Tiankang Biopharmacuetical Introduction and Business Overview
7.10.3 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Product Offerings
7.10.5 Tiankang Biopharmacuetical Recent Development
7.11 Vetal Company
7.11.1 Vetal Company Company Information
7.11.2 Vetal Company Introduction and Business Overview
7.11.3 Vetal Company Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Vetal Company Sheep and Goat Pox Vaccines Product Offerings
7.11.5 Vetal Company Recent Development
7.12 Veterinary Research Institute
7.12.1 Veterinary Research Institute Company Information
7.12.2 Veterinary Research Institute Introduction and Business Overview
7.12.3 Veterinary Research Institute Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Veterinary Research Institute Sheep and Goat Pox Vaccines Product Offerings
7.12.5 Veterinary Research Institute Recent Development
8 Industry Chain Analysis
8.1 Sheep and Goat Pox Vaccines Industrial Chain
8.2 Sheep and Goat Pox Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sheep and Goat Pox Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Sheep and Goat Pox Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Sheep and Goat Pox Vaccines Market Trends
    Table 2. Sheep and Goat Pox Vaccines Market Drivers & Opportunity
    Table 3. Sheep and Goat Pox Vaccines Market Challenges
    Table 4. Sheep and Goat Pox Vaccines Market Restraints
    Table 5. Global Sheep and Goat Pox Vaccines Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Sheep and Goat Pox Vaccines Revenue Market Share by Company (2019-2024)
    Table 7. Global Sheep and Goat Pox Vaccines Sales Volume by Company (2019-2024) & (M Units)
    Table 8. Global Sheep and Goat Pox Vaccines Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Sheep and Goat Pox Vaccines Price by Company (2019-2024) & (USD/K Unit)
    Table 10. Key Manufacturers Sheep and Goat Pox Vaccines Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Sheep and Goat Pox Vaccines Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Sheep and Goat Pox Vaccines
    Table 13. Global Sheep and Goat Pox Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sheep and Goat Pox Vaccines as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Sheep and Goat Pox Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Sheep and Goat Pox Vaccines Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Sheep and Goat Pox Vaccines Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Sheep and Goat Pox Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Sheep and Goat Pox Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Sheep and Goat Pox Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (M Units)
    Table 22. Global Sheep and Goat Pox Vaccines Sales Volume by Type (2019-2024) & (M Units)
    Table 23. Global Sheep and Goat Pox Vaccines Sales Volume by Type (2025-2030) & (M Units)
    Table 24. Global Sheep and Goat Pox Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Sheep and Goat Pox Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Sheep and Goat Pox Vaccines Price by Type (2019-2024) & (USD/K Unit)
    Table 27. Global Sheep and Goat Pox Vaccines Price by Type (2025-2030) & (USD/K Unit)
    Table 28. Global Sheep and Goat Pox Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Sheep and Goat Pox Vaccines Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Sheep and Goat Pox Vaccines Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Sheep and Goat Pox Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Sheep and Goat Pox Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Sheep and Goat Pox Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (M Units)
    Table 34. Global Sheep and Goat Pox Vaccines Sales Volume by Application (2019-2024) & (M Units)
    Table 35. Global Sheep and Goat Pox Vaccines Sales Volume by Application (2025-2030) & (M Units)
    Table 36. Global Sheep and Goat Pox Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Sheep and Goat Pox Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Sheep and Goat Pox Vaccines Price by Application (2019-2024) & (USD/K Unit)
    Table 39. Global Sheep and Goat Pox Vaccines Price by Application (2025-2030) & (USD/K Unit)
    Table 40. Global Sheep and Goat Pox Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Sheep and Goat Pox Vaccines Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Sheep and Goat Pox Vaccines Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Sheep and Goat Pox Vaccines Sales Value by Region (2019-2024) & (%)
    Table 44. Global Sheep and Goat Pox Vaccines Sales Value by Region (2025-2030) & (%)
    Table 45. Global Sheep and Goat Pox Vaccines Sales Volume by Region (M Units): 2019 VS 2023 VS 2030
    Table 46. Global Sheep and Goat Pox Vaccines Sales Volume by Region (2019-2024) & (M Units)
    Table 47. Global Sheep and Goat Pox Vaccines Sales Volume by Region (2025-2030) & (M Units)
    Table 48. Global Sheep and Goat Pox Vaccines Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Sheep and Goat Pox Vaccines Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Sheep and Goat Pox Vaccines Average Price by Region (2019-2024) & (USD/K Unit)
    Table 51. Global Sheep and Goat Pox Vaccines Average Price by Region (2025-2030) & (USD/K Unit)
    Table 52. Key Countries/Regions Sheep and Goat Pox Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Sheep and Goat Pox Vaccines Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Sheep and Goat Pox Vaccines Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Sheep and Goat Pox Vaccines Sales Volume, (2019-2024) & (M Units)
    Table 56. Key Countries/Regions Sheep and Goat Pox Vaccines Sales Volume, (2025-2030) & (M Units)
    Table 57. Agrovet Company Information
    Table 58. Agrovet Introduction and Business Overview
    Table 59. Agrovet Sheep and Goat Pox Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 60. Agrovet Sheep and Goat Pox Vaccines Product Offerings
    Table 61. Agrovet Recent Development
    Table 62. Biopharma Company Information
    Table 63. Biopharma Introduction and Business Overview
    Table 64. Biopharma Sheep and Goat Pox Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 65. Biopharma Sheep and Goat Pox Vaccines Product Offerings
    Table 66. Biopharma Recent Development
    Table 67. Dollvet Company Information
    Table 68. Dollvet Introduction and Business Overview
    Table 69. Dollvet Sheep and Goat Pox Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 70. Dollvet Sheep and Goat Pox Vaccines Product Offerings
    Table 71. Dollvet Recent Development
    Table 72. FGBI - Federal Centre for Animal Health Company Information
    Table 73. FGBI - Federal Centre for Animal Health Introduction and Business Overview
    Table 74. FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 75. FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Product Offerings
    Table 76. FGBI - Federal Centre for Animal Health Recent Development
    Table 77. Hester Biosciences Limited Company Information
    Table 78. Hester Biosciences Limited Introduction and Business Overview
    Table 79. Hester Biosciences Limited Sheep and Goat Pox Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 80. Hester Biosciences Limited Sheep and Goat Pox Vaccines Product Offerings
    Table 81. Hester Biosciences Limited Recent Development
    Table 82. Indian Immunologicals Limited Company Information
    Table 83. Indian Immunologicals Limited Introduction and Business Overview
    Table 84. Indian Immunologicals Limited Sheep and Goat Pox Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 85. Indian Immunologicals Limited Sheep and Goat Pox Vaccines Product Offerings
    Table 86. Indian Immunologicals Limited Recent Development
    Table 87. Institut Pasteur d'Algerie Company Information
    Table 88. Institut Pasteur d'Algerie Introduction and Business Overview
    Table 89. Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 90. Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Product Offerings
    Table 91. Institut Pasteur d'Algerie Recent Development
    Table 92. Intervac (PVT) Ltd. Company Information
    Table 93. Intervac (PVT) Ltd. Introduction and Business Overview
    Table 94. Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 95. Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Product Offerings
    Table 96. Intervac (PVT) Ltd. Recent Development
    Table 97. JOVAC Company Information
    Table 98. JOVAC Introduction and Business Overview
    Table 99. JOVAC Sheep and Goat Pox Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 100. JOVAC Sheep and Goat Pox Vaccines Product Offerings
    Table 101. JOVAC Recent Development
    Table 102. Tiankang Biopharmacuetical Company Information
    Table 103. Tiankang Biopharmacuetical Introduction and Business Overview
    Table 104. Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 105. Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Product Offerings
    Table 106. Tiankang Biopharmacuetical Recent Development
    Table 107. Vetal Company Company Information
    Table 108. Vetal Company Introduction and Business Overview
    Table 109. Vetal Company Sheep and Goat Pox Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 110. Vetal Company Sheep and Goat Pox Vaccines Product Offerings
    Table 111. Vetal Company Recent Development
    Table 112. Veterinary Research Institute Company Information
    Table 113. Veterinary Research Institute Introduction and Business Overview
    Table 114. Veterinary Research Institute Sheep and Goat Pox Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 115. Veterinary Research Institute Sheep and Goat Pox Vaccines Product Offerings
    Table 116. Veterinary Research Institute Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Sheep and Goat Pox Vaccines Downstream Customers
    Table 120. Sheep and Goat Pox Vaccines Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sheep and Goat Pox Vaccines Product Picture
    Figure 2. Global Sheep and Goat Pox Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Sheep and Goat Pox Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Sheep and Goat Pox Vaccines Sales Volume (2019-2030) & (M Units)
    Figure 5. Global Sheep and Goat Pox Vaccines Sales Price (2019-2030) & (USD/K Unit)
    Figure 6. Sheep and Goat Pox Vaccines Report Years Considered
    Figure 7. Global Sheep and Goat Pox Vaccines Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Sheep and Goat Pox Vaccines Players Sales Volume Ranking (2023) & (M Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Sheep and Goat Pox Vaccines Revenue in 2023
    Figure 10. Sheep and Goat Pox Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Attenuated Live Vaccines Picture
    Figure 12. Killed Vaccines Picture
    Figure 13. Global Sheep and Goat Pox Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Sheep and Goat Pox Vaccines Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Sheep and Goat Pox Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (M Units)
    Figure 16. Global Sheep and Goat Pox Vaccines Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Sheep and Goat Pox Vaccines Price by Type (2019-2030) & (USD/K Unit)
    Figure 18. Product Picture of Sheep
    Figure 19. Product Picture of Goat
    Figure 20. Global Sheep and Goat Pox Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Sheep and Goat Pox Vaccines Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Sheep and Goat Pox Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (M Units)
    Figure 23. Global Sheep and Goat Pox Vaccines Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Sheep and Goat Pox Vaccines Price by Application (2019-2030) & (USD/K Unit)
    Figure 25. North America Sheep and Goat Pox Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Sheep and Goat Pox Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Sheep and Goat Pox Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Sheep and Goat Pox Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Sheep and Goat Pox Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Sheep and Goat Pox Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Sheep and Goat Pox Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Sheep and Goat Pox Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Sheep and Goat Pox Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Sheep and Goat Pox Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Sheep and Goat Pox Vaccines Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Sheep and Goat Pox Vaccines Sales Volume (%), (2019-2030)
    Figure 37. United States Sheep and Goat Pox Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Sheep and Goat Pox Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Sheep and Goat Pox Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Sheep and Goat Pox Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Sheep and Goat Pox Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Sheep and Goat Pox Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Sheep and Goat Pox Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Sheep and Goat Pox Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Sheep and Goat Pox Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Sheep and Goat Pox Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Sheep and Goat Pox Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Sheep and Goat Pox Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Sheep and Goat Pox Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Sheep and Goat Pox Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Sheep and Goat Pox Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Sheep and Goat Pox Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Sheep and Goat Pox Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Sheep and Goat Pox Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Sheep and Goat Pox Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Sheep and Goat Pox Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Sheep and Goat Pox Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 58. Sheep and Goat Pox Vaccines Industrial Chain
    Figure 59. Sheep and Goat Pox Vaccines Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS